Mechanical Circulatory Support Devices (Cardiovascular) - Global Market Analysis and Forecast Model
Mechanical Circulatory Support Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Mechanical Circulatory Support Devices market for the year 2020 and beyond. Mechanical Circulatory Support Devices are devices which replace or assist the pumping function of the ventricles. These devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery post cardiotomy. They are a treatment option for end stage heart failure through the use of a ventricular assist device (VAD), also known as a heart pump, which is a mechanical circulatory assist device that helps pump blood from the heart to the rest of the body.
There are two types of implantable VADs: Left Ventricular Assist Devices (LVADs) and Right Ventricular Assist Devices (RVADs) which support the left and right ventricle respectively. Another treatment option for end stage heart failure is through the implantation of a total artificial heart. A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Mechanical Circulatory Support Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Abbott Laboratories, Medtronic plc, Syncardia Systems LLC, Berlin Heart GmbH, Zelenograd Innovation and Technology Center, Jarvik Heart Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -